We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$61.8B
AUM Growth
+$4.26B
Cap. Flow
-$26.3M
Cap. Flow %
-0.04%
Top 10 Hldgs %
23.07%
Holding
1,147
New
131
Increased
370
Reduced
316
Closed
101

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$317M
2
TAP icon
Molson Coors Class B
TAP
+$279M
3
NSC icon
Norfolk Southern
NSC
+$213M
4
CSX icon
CSX Corp
CSX
+$198M
5
MDT icon
Medtronic
MDT
+$195M

Sector Composition

Rank Sector Weight
1 Technology 18.75%
2 Healthcare 13.11%
3 Financials 12.08%
4 Industrials 11.44%
5 Communication Services 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STZ icon
951
Constellation Brands
STZ
$22.2B
$2K ﹤0.01%
11
UBS icon
952
UBS Group
UBS
$173B
$2K ﹤0.01%
+149
New +$2.34K
CYHHZ
953
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$2K ﹤0.01%
456,161
CRTO icon
954
Criteo S.A. Ordinary Shares
CRTO
$1.1B
$1K ﹤0.01%
75
-3,495
-98% -$98.9K
SIRI icon
955
SiriusXM
SIRI
$9.98B
$1K ﹤0.01%
18
VIRT icon
956
Virtu Financial
VIRT
$5.11B
$1K ﹤0.01%
80
-104,513
-100% -$2.38M
ALXN
957
DELISTED
Alexion Pharmaceuticals
ALXN
$1K ﹤0.01%
12
ADAP
958
DELISTED
Adaptimmune Therapeutics
ADAP
-160,892
Closed -$1.91M
ALNY icon
959
Alnylam Pharmaceuticals
ALNY
$27.5B
-6,228
Closed -$613K
AU icon
960
AngloGold Ashanti
AU
$40.1B
-24,479
Closed -$200K
BFAM icon
961
Bright Horizons
BFAM
$3.92B
-730
Closed -$74K
BMRN icon
962
BioMarin Pharmaceuticals
BMRN
$11.6B
-18,427
Closed -$1.74M
BBBY
963
Bed Bath & Beyond
BBBY
$481M
-6,179
Closed -$156K
CCI icon
964
Crown Castle
CCI
$33.3B
$0 ﹤0.01%
1
-860
-100% -$95.8K
CDXS icon
965
Codexis
CDXS
$151M
-94,366
Closed -$1.36M
CENTA icon
966
Central Garden & Pet Co Class A
CENTA
$2.37B
-6,431
Closed -$208K
CF icon
967
CF Industries
CF
$19.2B
-4,820
Closed -$214K
CHDN icon
968
Churchill Downs
CHDN
$5.88B
-1,740
Closed -$85K
CME icon
969
CME Group
CME
$96.3B
$0 ﹤0.01%
1
-734
-100% -$124K
CNA icon
970
CNA Financial
CNA
$14.2B
-49,380
Closed -$2.25M
COLL icon
971
Collegium Pharmaceutical
COLL
$1.15B
-8,405
Closed -$200K
CSL icon
972
Carlisle Companies
CSL
$14.3B
-1,000
Closed -$108K
DAN icon
973
Dana Inc
DAN
$2.9B
-38,348
Closed -$774K
DLX icon
974
Deluxe
DLX
$1.18B
-614,312
Closed -$40.7M
ECL icon
975
Ecolab
ECL
$78.1B
-73,505
Closed -$10.3M

Similar funds

Lazard Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Lazard Asset Management held 1,147 positions worth $61.8B, up 7.4% from $57.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lazard Asset Management's Q3 2018 filing shows 131 new, 370 increased, 316 reduced and 101 closed positions. Its largest new stake was Rogers Communications: 1,642,507 shares worth $84.4M. The largest sale was PG&E, an estimated $317M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Lazard Asset Management's largest Q3 2018 buy was Rogers Communications: 1,642,507 shares worth $84.4M.
  • Lazard Asset Management added most to Armstrong World Industries in Q3 2018, an estimated $362M increase.
  • Lazard Asset Management's biggest Q3 2018 reduction was PG&E, cutting an estimated $317M.
  • Lazard Asset Management fully exited Vipshop in Q3 2018, selling an estimated $46.4M.
  • Lazard Asset Management's ten largest holdings make up 23% of its $61.8B portfolio in Q3 2018.
  • Lazard Asset Management opened 131 new positions and closed 101 in Q3 2018.
  • Lazard Asset Management's portfolio value rose 7.4% quarter-over-quarter to $61.8B.

Based on Lazard Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.